Electrocochleography and cognition are important predictors of speech perception outcomes in noise for cochlear implant recipients

Amit Walia(Washington University in St. Louis), Craig A. Buchman(Washington University in St. Louis), Dorina Kallogjeri(Washington University in St. Louis), Matthew Shew(Washington University in St. Louis), Cameron C. Wick(Washington University in St. Louis), Jacques A. Herzog(Washington University in St. Louis), Shannon M. Lefler(Washington University in St. Louis), Nedim Durakovic(Washington University in St. Louis), Amanda J. Ortmann(Washington University in St. Louis)
Scientific Reports
February 23, 2022
10.1038/s41598-022-07175-7
Cited by 52

Related Papers

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
|Clinical Cancer Research|2020|368
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications
|Biochimica et Biophysica Acta (BBA) - General Subjects|2015|180
Unilateral Cochlear Implants for Severe, Profound, or Moderate Sloping to Profound Bilateral Sensorineural Hearing Loss
|JAMA Otolaryngology–Head & Neck Surgery|2020|140
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
|Science Immunology|2023|118
Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC).
|Journal of Clinical Oncology|2021|40